CDIO
NASDAQ · Biotechnology
Cardio Diagnostics Holdings
$1.89
-0.06 (-2.88%)
Open$1.94
Previous Close$1.95
Day High$1.95
Day Low$1.88
52W High$7.91
52W Low$0.97
Volume—
Avg Volume33.5K
Market Cap5.65M
P/E Ratio—
EPS$-2.92
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,644.1% upside
Current
$1.89
$1.89
Target
$33.03
$33.03
$21.42
$33.03 avg
$37.66
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 25.2K | 758.5K | 743.9K |
| Net Income | -10,980,222 | -209,998 | -203,473 |
| Profit Margin | -43,817.7% | -27.7% | -27.4% |
| EBITDA | -10,846,158 | -263,366 | -243,311 |
| Free Cash Flow | — | -217,938 | -231,433 |
| Rev Growth | — | -7.2% | +1.3% |
| Debt/Equity | 0.04 | 0.72 | 0.58 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |